GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tchaikapharma Highquality Medicines AD (XBUL:THQM) » Definitions » EPS (Basic)

Tchaikapharma Highquality Medicines AD (XBUL:THQM) EPS (Basic) : лв0.04 (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Tchaikapharma Highquality Medicines AD EPS (Basic)?

Tchaikapharma Highquality Medicines AD's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was лв0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was лв0.04.

Tchaikapharma Highquality Medicines AD's EPS (Diluted) for the three months ended in Mar. 2024 was лв0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was лв0.03.

Tchaikapharma Highquality Medicines AD's EPS without NRI for the three months ended in Mar. 2024 was лв0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 0.03.

During the past 12 months, Tchaikapharma Highquality Medicines AD's average EPS without NRIGrowth Rate was 88.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 78.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -14.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Tchaikapharma Highquality Medicines AD's highest 3-Year average EPS without NRI Growth Rate was 78.80% per year. The lowest was -61.40% per year. And the median was -36.80% per year.


Tchaikapharma Highquality Medicines AD EPS (Basic) Historical Data

The historical data trend for Tchaikapharma Highquality Medicines AD's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tchaikapharma Highquality Medicines AD EPS (Basic) Chart

Tchaikapharma Highquality Medicines AD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Basic)
Get a 7-Day Free Trial 0.03 0.01 0.02 0.03 0.04

Tchaikapharma Highquality Medicines AD Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 - -0.01 0.02

Tchaikapharma Highquality Medicines AD EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Tchaikapharma Highquality Medicines AD's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3.398-0)/84.500
=0.04

Tchaikapharma Highquality Medicines AD's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1.466-0)/89.475
=0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tchaikapharma Highquality Medicines AD  (XBUL:THQM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Tchaikapharma Highquality Medicines AD EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Tchaikapharma Highquality Medicines AD's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Tchaikapharma Highquality Medicines AD (XBUL:THQM) Business Description

Traded in Other Exchanges
N/A
Address
1 G. M. Dimitrov Boulevard, Sofia, BGR, 1172
Tchaikapharma Highquality Medicines AD is engaged in the business of manufacturing and selling pharmaceuticals in Bulgaria. It manufactures medicines for cancer, heart diseases, respiratory problems, and neurological diseases, among others.

Tchaikapharma Highquality Medicines AD (XBUL:THQM) Headlines

No Headlines